Viewing Study NCT02547805

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-02-24 @ 10:06 AM
Study NCT ID: NCT02547805
Status: COMPLETED
Last Update Posted: 2017-01-19
First Post: 2015-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
Sponsor: Allena Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Secondary Hyperoxaluria View
None Nephrolithiasis View
None Hyperoxaluria View
None Kidney Stones View
None Dietary Hyperoxaluria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Urine Oxalate View
None Nephrolithiasis View
None Kidney Stones View
None Hyperoxaluria View
None Enteric Hyperoxaluria View
None Idiopathic Hyperoxaluria View
None Urological Diseases View
None Kidney Diseases View
None Supersaturation View
None Dietary Oxalate View